The intersection of photonics, microfluidics, and biocompatible materials is defining the next era of medical device innovation. As MD&M West 2026 approaches, FEMTOPRINT prepares to unveil transformative solutions in 3D glass microfabrication.
The medical device industry is currently facing a dual challenge: the demand for extreme miniaturization and the necessity for uncompromising reliability. At MD&M West 2026 (Anaheim, CA), FEMTOPRINT will demonstrate how monolithic glass integration is solving these complexities, offering a level of precision that traditional manufacturing methods struggle to achieve.
Glass has emerged as the material of choice for high-precision medical applications due to its exceptional chemical inertness, optical clarity, and thermal stability. However, the true breakthrough lies in the ability to manipulate it at the micron scale.
At Booth #537, our focus will be on the synergy between advanced 3D microfabrication and predictive modeling.
Why come to visti us:
Optimize Scalability is our goal. Align complex design specifications with high-volume production requirements, ensuring a seamless transition from R&D to market.
Mitigate Risk: Reduce development cycles and regulatory friction by utilizing validated simulation data
Whether your challenges involve ISO 13485 compliance, the integration of micro-optics into diagnostic platforms, or the development of next-generation surgical instruments, our team is prepared to discuss how 3D micro-engineering can accelerate your path to commercialization.
The future of MedTech is built on precision. Join us in Anaheim to explore how FEMTOPRINT is engineering the breakthroughs of tomorrow.
For more information or to book a private technical session, contact us.
